Specification:
End Application:
Discover blue-ribbon protection with Paxista Tablets, designed for the emergency treatment of mild-to-moderate COVID-19 under stringent medical supervision. Procure this pharmaceutical-grade, customizable antiviral-each tablet contains 150 mg Nirmatrelvir and 100 mg Ritonavir, delivering astonishing efficacy. Marketed by Azista in blister packs, Paxista guarantees purity (99%) and instant savings through efficient procurement. With a remarkable shelf life of 2 years, it is suitable for all age groups. Instant administration is oral, with clear dosage guidelines from your physician. Available as a prescription-only medication in India, the product is ideal for dealers, exporters, and healthcare providers.
Phenomenal Features and Plant Application
Paxista Tablets feature a meticulous combination of Nirmatrelvir and Ritonavir, crafted for blue-ribbon antiviral activity. Application media includes oral administration in healthcare facilities, clinics, and hospitals. These tablets are engineered for use across diverse plant settings, supporting public health with rapid, scalable deployment. With its pharmaceutical-grade formulation and customizable options, Paxista remains a leading choice for distributors, service providers, and end-users looking for reliable COVID-19 care.
Sample Policy and Global Market Value
Order completion is streamlined under our sample policy, ensuring clarity for potential buyers. Samples of Paxista Tablets are available upon request, allowing evaluation prior to bulk procurement. Shipped goods meet rigorous standards, with delivery mechanisms optimized for India and major international export markets. The product strengthens market value due to its pharmaceutical-grade quality, wide efficacy, and trusted reputation as a top-tier COVID-19 treatment.
Phenomenal Features and Plant Application
Paxista Tablets feature a meticulous combination of Nirmatrelvir and Ritonavir, crafted for blue-ribbon antiviral activity. Application media includes oral administration in healthcare facilities, clinics, and hospitals. These tablets are engineered for use across diverse plant settings, supporting public health with rapid, scalable deployment. With its pharmaceutical-grade formulation and customizable options, Paxista remains a leading choice for distributors, service providers, and end-users looking for reliable COVID-19 care.
Sample Policy and Global Market Value
Order completion is streamlined under our sample policy, ensuring clarity for potential buyers. Samples of Paxista Tablets are available upon request, allowing evaluation prior to bulk procurement. Shipped goods meet rigorous standards, with delivery mechanisms optimized for India and major international export markets. The product strengthens market value due to its pharmaceutical-grade quality, wide efficacy, and trusted reputation as a top-tier COVID-19 treatment.